What is the risk of cancer associated with adalimumab in a patient with COPD and a family history of cancer?
No direct evidence for the risk of cancer associated with adalimumab in patients with COPD and a family history of cancer exists. Indirect evidence suggests potential safety concerns, but further studies are necessary to clarify these risks in the specified population.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-10-26
- DOI
- https://doi.org/10.5281/zenodo.23665559
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00